Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
36.0%
% of FTXH's 51 holdings also in PBE
64.3%
% of PBE's 28 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 3.7% | 5.0% | 3.7% |
|
BIOGEN IDEC INC | 3.7% | 5.0% | 3.7% |
|
GILEAD SCIENCES INC | 3.7% | 5.1% | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.6% | 4.4% | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.4% | 4.5% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PBE
|
BRISTOL-MYERS SQUIBB CO | 7.6% |
|
JOHNSON & JOHNSON | 7.5% |
|
ABBVIE INC | 7.4% |
|
MERCK & CO. INC. | 7.3% |
|
PFIZER INC | 7.2% |
|
ZOETIS INC | 3.7% |
|
VIATRIS, INC. | 3.5% |
|
ELI LILLY & CO | 3.4% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
ORGANON & CO. | 2.6% |
FTXH Underweight Relative to PBE
|
NATERA INC | -4.7% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.9% |
|
NEUROCRINE BIOSCIENCES INC | -3.7% |
|
TG THERAPEUTICS INC | -3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
DYNAVAX TECHNOLOGIES CORP | -2.9% |
|
ILLUMINA INC | -2.7% |
|
BIOCRYST PHARMACEUTICALS INC | -2.7% |
|
ROYALTY PHARMA PLC CLASS A | -2.6% |
|
CATALYST PHARMACEUTICAL PART | -2.6% |